Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04551352
Title A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche

skin melanoma

uveal melanoma

mucosal melanoma


RO7293583 + Tocilizumab

Obinutuzumab + RO7293583 + Tocilizumab

Age Groups: adult | senior
Covered Countries USA | ESP | CAN | BEL

No variant requirements are available.